Production (Stage)
Hepion Pharmaceuticals, Inc.
HEPA
$0.0722
$0.009214.60%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.59M | 406.40K | 1.50M | 2.12M | 13.11M |
Total Receivables | -- | -- | 600.00K | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.73M | 1.21M | 1.43M | 3.37M | 2.32M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 6.32M | 1.61M | 3.53M | 5.48M | 15.43M |
|
|||||
Total Current Assets | 6.32M | 1.61M | 3.53M | 5.48M | 15.43M |
Net Property, Plant & Equipment | -- | 0.00 | 118.30K | 150.70K | 182.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 66.50K | 377.00K | 377.00K |
Total Assets | 6.32M | 1.61M | 3.72M | 6.01M | 15.99M |
|
|||||
Total Accounts Payable | 243.30K | 220.20K | 186.30K | 446.50K | 1.50M |
Total Accrued Expenses | 166.50K | 23.70K | 306.00K | 375.00K | 793.80K |
Short-term Debt | 526.20K | 2.90M | 2.11M | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 118.00K | 154.10K | 134.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 149.00K |
Total Other Current Liabilities | -- | -- | -- | -- | 149.00K |
Total Current Liabilities | 935.90K | 3.14M | 2.72M | 975.60K | 2.57M |
|
|||||
Total Current Liabilities | 935.90K | 3.14M | 2.72M | 975.60K | 2.57M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 526.20K | 2.90M | 2.11M | -- | -- |
Capital Leases | -- | -- | -- | -- | 41.20K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.49M | 333.20K | 1.41M | 1.47M | 5.85M |
Total Liabilities | 2.42M | 3.48M | 4.12M | 2.45M | 8.47M |
|
|||||
Common Stock & APIC | 246.12M | 234.25M | 234.22M | 233.33M | 233.30M |
Retained Earnings | -243.93M | -237.82M | -236.27M | -231.41M | -227.48M |
Treasury Stock & Other | 8.30K | 8.30K | -53.80K | -53.80K | 9.20K |
Total Common Equity | 2.20M | -3.56M | -2.10M | 1.87M | 5.83M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
|
|||||
Total Common Equity | 2.20M | -3.56M | -2.10M | 1.87M | 5.83M |
Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.90M | -1.86M | -406.70K | 3.56M | 7.52M |
|